Clinical trial

A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data

NCT06854341

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2024-02-09

PhaseN/A

Study timeline

Study start (actual)2024-02-09Date precision: day

Registry last updated2025-03-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Interventions

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06854341 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.